A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F

Cell

Volumn 70, Issue 2, 1992, Pages 337-350

  Helin, Kristian ^a   Lees, Jacqueline A ^a   Vidal, Marc ^a   Dyson, Nicholas ^a   Harlow, Ed ^a   Fattaey, Ali ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL EXTRACT; COMPLEMENTARY DNA; COMPLEMENTARY RNA; GENE PRODUCT; HYBRID PROTEIN; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ADENOVIRUS; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; DNA METHYLATION; DNA SEQUENCE; DNA TRANSFECTION; ENZYME ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; BINDING, COMPETITIVE; CARRIER PROTEINS; CLONING, MOLECULAR; DNA; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; RETINOBLASTOMA PROTEIN; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS; VIRAL PROTEINS;

ADENOVIRIDAE;

EID: 0026652346     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(92)90107-N     Document Type: Article

References (79)

1. Activation of DNA binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor
2. Phosphorylation-dependent activation of the adenovirus-inducible E2F factor in a cell-free system
3. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation
4. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor
5. Cyclin A and the retinoblastoma gene product complex with a common transcription factor
6. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo
7. A film detection method for tritium-labeled proteins and nucleic acids in polyacrylamide gels
8. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene
9. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
10. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F
11. The E2F transcription factor is a cellular target for the RB protein
12. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation
13. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein
14. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
15. Empirical prediction of protein conformation
16. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
17. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element
18. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product
19. Firefly luciferase gene: structure and expression in mammalian cells
20. Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement
21. Identification of germline and somatic mutations affecting the retinoblastoma gene
22. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
23. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein
24. Adenovirus E1A makes two distinct contacts with the retinoblastoma protein
25. Purification and characterization of a functionally homogeneous 60-kda species of the retinoblastoma gene product
26. Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins
27. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
28. Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein
29. Structural evidence for the authenticity of the human retinoblastoma gene
30. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins
31. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
32. A new technique for the assay of infectivity of human adenovirus
33. Monoclonal antibodies specific for simian virus 40 tumor antigens
34. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products
35. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products
36. E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor
37. Role of E2F transcription factor in E1A-mediated trans-activation of cellular genes
38. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F
39. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells
40. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations
41. Antibodies specific for the human retinoblastoma protein identify a family of related polypepides
42. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells
43. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen
44. A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product
45. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product
46. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product
47. Expression cloning of a cDNA encoding a retinoblastoma binding protein with E2F-like properties
48. Identification of a cellular transcription factor involved in E1A trans-activation
49. Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs
50. Maturation of the head of bacteriophage T4. I. DNA packaging events
51. The embryonal carcinoma stem cell E1a-like activity involves a differentiation-regulated transcription factor
52. Human retinoblastoma susceptibility gene: cloning, identification, and sequence
53. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
54. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2
55. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase
56. The adenovirus EIIA enhancer
57. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family
58. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T
59. Identification of an AUUUA-specific messenger RNA binding protein
60. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
61. G1/S phosphorylation of the retinoblastoma protein is associated with altered affinity for the nuclear compartment
62. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway
63. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A
64. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
65. Identification of an E1A-inducible cellular factor that interacts with regulatory sequences within the adenovirus E4 promoter
66. Activation of the E2F transcription factor in adenovirus infected cells involves an E1A-dependent stimulation of DNA binding activity and induction of cooperative binding mediated by an E4 gene product
67. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product
68. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
69. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation
70. Multicomponent differentiation-regulated transcription factors in F9 embryonal carcinoma stem cells
71. A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eukaryotic cells
72. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
73. Expression of the RB gene under the control of MuLV-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblastoma cells in immunodefective mice
74. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase
75. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
76. Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multi-component complex
77. The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding